Engineering Micro Oxygen Factories to Slow Tumour Progression Via Hyperoxic Microenvironments
Overview
Authors
Affiliations
While hypoxia promotes carcinogenesis, tumour aggressiveness, metastasis, and resistance to oncological treatments, the impacts of hyperoxia on tumours are rarely explored because providing a long-lasting oxygen supply in vivo is a major challenge. Herein, we construct micro oxygen factories, namely, photosynthesis microcapsules (PMCs), by encapsulation of acquired cyanobacteria and upconversion nanoparticles in alginate microcapsules. This system enables a long-lasting oxygen supply through the conversion of external radiation into red-wavelength emissions for photosynthesis in cyanobacteria. PMC treatment suppresses the NF-kB pathway, HIF-1α production and cancer cell proliferation. Hyperoxic microenvironment created by an in vivo PMC implant inhibits hepatocarcinoma growth and metastasis and has synergistic effects together with anti-PD-1 in breast cancer. The engineering oxygen factories offer potential for tumour biology studies in hyperoxic microenvironments and inspire the exploration of oncological treatments.
Bioinspired micro- and nanostructured systems for cancer therapy.
Yang R, Zhang B, Fei X, Cong S, Zhao S, Zhou T MedComm (2020). 2024; 5(12):e70025.
PMID: 39619230 PMC: 11604729. DOI: 10.1002/mco2.70025.
Nanotechnology based gas delivery system: a "green" strategy for cancer diagnosis and treatment.
Chen M, Xu T, Song L, Sun T, Xu Z, Zhao Y Theranostics. 2024; 14(14):5461-5491.
PMID: 39310098 PMC: 11413789. DOI: 10.7150/thno.98884.
Synthetic vectors for activating the driving axis of ferroptosis.
Jiang J, Yang L, Xie Q, Liu X, Jiang J, Zhang J Nat Commun. 2024; 15(1):7923.
PMID: 39256387 PMC: 11387475. DOI: 10.1038/s41467-024-52312-7.
Song J, Feng Y, Yan J, Wang Y, Yan W, Yang N Adv Sci (Weinh). 2024; 11(38):e2405192.
PMID: 39102342 PMC: 11481196. DOI: 10.1002/advs.202405192.
Sonosynthetic Cyanobacteria Oxygenation for Self-Enhanced Tumor-Specific Treatment.
Yang Z, Shen X, Jin J, Jiang X, Pan W, Wu C Adv Sci (Weinh). 2024; 11(29):e2400251.
PMID: 38867396 PMC: 11304326. DOI: 10.1002/advs.202400251.